INNOVACIONES DISRAS, S.L. – Trademark Portfolio
Entity Type: 99
INNOVACIONES DISRAS, S.L. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OTOSTICK.
C/Los Pedregales 66 E-06400 DON BENITO(BADAJOZ)
Polígono Industrial San Isidro, ADAJOZ)
Showing of trademarks Trademarks
Trademark Classifications
INNOVACIONES DISRAS, S.L.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does INNOVACIONES DISRAS, S.L. have?
INNOVACIONES DISRAS, S.L. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does INNOVACIONES DISRAS, S.L. file in?
INNOVACIONES DISRAS, S.L. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are INNOVACIONES DISRAS, S.L.'s most well-known trademarks?
INNOVACIONES DISRAS, S.L.'s registered trademark portfolio includes well-known marks such as OTOSTICK. These are among 1 currently registered trademark in the portfolio.
What is INNOVACIONES DISRAS, S.L.'s trademark registration success rate?
INNOVACIONES DISRAS, S.L. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.